Publications

6430 items matching your search terms.

Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development

Bianco-Miotto, T.; Chiam, K.; Buchanan, G.; Jindal, S.; Day, T. K.; Thomas, M.; Pickering, M. A.; O'Loughlin, M. A.; Ryan, N. K.; Raymond, W. A.; Horvath, L. G.; Kench, J. G.; Stricker, P. D.; Marshall, V. R.; Sutherland, R. L.; Henshall, S. M.; Gerald, W. L.; Scher, H. I.; Risbridger, G. P.; Clements, J. A.; Butler, L. M.; Tilley, W. D.; Horsfall, D. J.; Ricciardelli, C.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 19 (10) :2611-22, 2010 1055-9965.EPI-10-0555 [pii] 10.1158/1055-9965.EPI-10-0555

A rational guide to reducing fracture risk in dialysis patients

Toussaint, N,D.; Elder, G.J.; Kerr, P.G.

SEMINARS IN DIALYSIS 23 (1) :43-54, 2010 SDI650 [pii] 10.1111/j.1525-139X.2009.00650.x

The osteoclast differentiation factors RANKL/RANK control development of progesterone-driven breast cancer

Schramek, D.; Leibbrandt, A.; Sigl, V.; Kenner, L.; Pospisilik, J. A.; Lee, H. J.; Hanada, R.; Joshi, P. A.; Aliprantis, A.; Glimcher, L.; Pasparakis, M.; Khokha, R.; Ormandy, C. J.; Widschwendter, M.; Schett, G.; Penninger, J. M.

NATURE 468 (7320) :98-102, 2010 nature09387 [pii] 10.1038/nature09387 10.1038/nature09387

Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects

Marshall, G.M.; Gherardi, S.; Xu, N.; Neiron, Z.; Trahair, T.; Scarlett, C.J.; Chang, D.K.; Liu, P.K.; Jankowski, K.; Iraci, N.; Haber, M.; Norris, M.D.; Keating, J.; Sekyere, E.; Stossi, F.; Katzenellenbogen, B.S.; Biankin, A.V.; Perini, G.; Liu, T.

ONCOGENE 29 (44) :5957-68, 2010 onc2010332 [pii] 10.1038/onc.2010.332

B-cell tolerance: mechanisms and implications

Basten, A.; Silveira, P.A.:

CURRENT OPINION IN IMMUNOLOGY 22 (5) :566-74, 2010 S0952-7915(10)00110-X [pii] 10.1016/j.coi.2010.08.001

Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets

Hislop, A. D.; Palendira, U.; Leese, A. M.; Arkwright, P. D.; Rohrlich, P. S.; Tangye, S. G.; Gaspar, H. B.; Lankester, A. C.; Moretta, A.; Rickinson, A. B.:

Blood 116 (17) :3249-57, 2010 blood-2009-09-238832 [pii] 10.1182/blood-2009-09-238832

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

Xue, A., Scarlett, C.J., Chung, L., Butturini, G., Scarpa, A., Gandy, R., Wilson, S.R., Baxter, R.C.; Smith, R.C.

British Journal of Cancer 103 (3) :391-400, 2010

Akt inhibitors reduce glucose uptake independently of their effects on Akt

Tan, S.; Ng, Y.; James, D.E.:

BIOCHEMICAL JOURNAL 432 (1) :191-7, 2010 BJ20100750 [pii] 10.1042/BJ20100750 10.1042/BJ20100750

A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans

Lee, P.; Greenfield, J.R.; Ho, K.K.Y.; Fulham, M.J.:

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM 299 (4) :E601-6, 2010 ajpendo.00298.2010 [pii] 10.1152/ajpendo.00298.2010

Expression, purification and characterization of recombinant interleukin-21

Lee, C. M.; McGuire, H.; Basten, A.; King, C.; Christ, D.;

JOURNAL OF IMMUNOLOGICAL METHODS 362 (1-2) :185-9, 2010

Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells

Croucher, D. R.; Rickwood, D.; Tactacan, C. M.; Musgrove, E. A.; Daly, R. J.:

MOLECULAR AND CELLULAR BIOLOGY 30 (21) :5057-70, 2010 MCB.00249-10 [pii] 10.1128/MCB.00249-10

Hypothalamic regulation of bone

Driessler, F.; Baldock, P. A.;

JOURNAL OF MOLECULAR ENDOCRINOLOGY 45 (4) :175-81, 2010

Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans

Tam, C. S.; Viardot, A.; Clement, K.; Tordjman, J.; Tonks, K.; Greenfield, J. R.; Campbell, L. V.; Samocha-Bonet, D.; Heilbronn, L. K.

DIABETES 59 (9) :2164-70, 2010 db10-0162 [pii] 10.2337/db10-0162

Using the transcription factor inhibitor of DNA binding 1 to selectively target endothelial progenitor cells offers novel strategies to inhibit tumor angiogenesis and growth

Mellick, A. S.; Plummer, P. N.; Nolan, D. J.; Gao, D.; Bambino, K.; Hahn, M. Catena, R.; Turner, V.; McDonnell, K.; Benezra, R.; Brink, R.; Swarbrick, A.; Mittal, V.

CANCER RESEARCH 70 (18) :7273-82, 2010 0008-5472.CAN-10-1142 [pii] 10.1158/0008-5472.CAN-10-1142

Therapeutic implications of advances in our understanding of transitional B-cell development in humans

Suryani, S.; Tangye, S.G.:

Expert Review of Clinical Immunology 6 (5) :765-75, 2010 10.1586/eci.10.55

Protocol matters: Which methylome are you actually studying?

Robinson, M.D.; Statham, A.L.; Speed, T.P.; Clark, S.J.

Epigenomics 2 (4) :587-598, 2010 10.2217/epi.10.36